Dermatitis

Papers
(The TQCC of Dermatitis is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Fragrance Skin Sensitization Evaluation and Human Testing: 30-Year Experience622
North American Contact Dermatitis Group Patch Test Results: 2017–201882
The Eczema Area and Severity Index—A Practical Guide65
North American Contact Dermatitis Group Patch Test Results: 2019–202051
Financial Burden of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States34
Dual Efficacy of Upadacitinib in 2 Patients With Concomitant Severe Atopic Dermatitis and Alopecia Areata28
Systemic Therapy for Atopic Dermatitis in Older Adults and Adults With Comorbidities: A Scoping Review and International Eczema Council Survey24
Transcriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With Dupilumab24
Impact of Gloves and Mask Use on Epidermal Barrier Function in Health Care Workers22
Patch Testing During Immunosuppressive Therapy: A Systematic Review21
Allergenic Ingredients in Health Care Hand Sanitizers in the United States19
Psoriasis-like Eruption triggered by Dupilumab Therapy18
Epidemiology and Burden of Sleep Disturbances in Atopic Dermatitis in US Adults17
Fragrance- and Botanical-Related Allergy and Associated Concomitant Reactions: A Retrospective Analysis of the North American Contact Dermatitis Group Data 2007–201616
Contact Dermatitis Associated With Hair Care Products: A Retrospective Analysis of the North American Contact Dermatitis Group Data, 2001–201616
Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 2b Study With Abrocitinib15
Mycosis Fungoides Unmasked by Dupilumab Treatment in a Patient With a History of Atopic Dermatitis15
The History of Surfactants and Review of Their Allergic and Irritant Properties14
Psoralen-Induced Phytophotodermatitis13
Allergic Contact Dermatitis, an Important Skin Reaction in Diabetes Device Users: A Systematic Review13
Failure of Dupilimab With Severe Prurigo Nodularis That Responded Well to Abrocitinib12
Cutaneous Reactions to Aluminum12
Sunscreens: A Review of UV Filters and Their Allergic Potential12
Measurement Properties of Patient Health Questionnaire 9 and Patient Health Questionnaire 2 in Adult Patients With Atopic Dermatitis12
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Cutaneous Adverse Reactions: A Review12
Allergic Contact Dermatitis From Topical Drugs: An Overview11
The Association of Bullous Pemphigoid With Atopic Dermatitis and Allergic Rhinitis—A Population-Based Study11
Allergen Content of Best-Selling Ethnic Versus Nonethnic Shampoos, Conditioners, and Styling Products11
Facial Personal Protective Equipment: Materials, Resterilization Methods, and Management of Occupation-Related Dermatoses10
Positive Patch Test Reactions to Carba Mix and Thiuram Mix: The North American Contact Dermatitis Group Experience (1994–2016)10
Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy Studies10
Upadacitinib for the Treatment of Atopic Dermatitis in a Spanish Cohort—Real Life: Fifty-Two–Week Follow-up Results10
Occupational Contact Dermatitis in Hospital Cleaning Workers10
Aluminum—Allergen of the Year 202210
General and Skin-Specific Health-Related Quality of Life in Patients With Atopic Dermatitis Before and During the COVID-19 Pandemic10
Weight of Evidence Approach for Skin Sensitization Potency Categorization of Fragrance Ingredients10
TikTok as a Source of Dermatologic Information on Atopic Dermatitis9
Allergic Contact Dermatitis to (Meth)Acrylates in Apple AirPods Headphones9
Dupilumab Significantly Modulates Pain and Discomfort in Patients With Atopic Dermatitis: A Post Hoc Analysis of 5 Randomized Clinical Trials9
Dupilumab in Elderly Patients With Severe Atopic Dermatitis9
Can We Separate Oral Lichen Planus from Allergic Contact Dermatitis and Should We Patch Test? A Systematic Review of Chronic Oral Lichenoid Lesions9
Atopic Dermatitis in Latin America: A Roadmap to Address Data Collection, Knowledge Gaps, and Challenges9
Salivary Cortisol Values and Personality Features of Atopic Dermatitis Patients: A Prospective Study8
Ocular Adverse Events in Patients With Atopic Dermatitis Treated With Upadacitinib: A Real-Life Experience8
Characterization of Residual Facial Dermatitis during Dupilumab Therapy: A Retrospective Chart Review to Delineate the Potential Role of Expanded Series Patch Testing8
Dystrophic Epidermolysis Bullosa Pruriginosa: Successfully Treated With Dupilumab8
Impact and Associations of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States8
Acetophenone Azine8
Autoimmune Progesterone Dermatitis: A Systematic Review8
Atopic Dermatitis Is Associated With Multiple Behavioral Problems in US Children and Adolescents7
Allergic Contact Dermatitis of the Scalp Associated With Scalp Applied Products: A Systematic Review of Topical Allergens7
Occupational Contact Dermatitis in Dental Personnel: A Retrospective Analysis of the North American Contact Dermatitis Group Data, 2001 to 20187
Skin Characteristics of Hairdresser Apprentices at the Beginning of Vocational Training7
Photopatch Testing in New Zealand: A 12-Year Retrospective Review7
Mental Health Symptoms and Functional Impairment in Children With Atopic Dermatitis7
Potential for Allergic Contact Dermatitis in Popular Hair Care Practices and Ingredients7
Off-label Studies on the Use of Ruxolitinib in Dermatology7
Further Evidence of Allergic Contact Dermatitis Caused by 2,2′-Methylenebis(6-tert-Butyl-4-Methylphenol) Monoacrylate, a New Sensitizer in the Dexcom G6 Glucose Sensor7
Contact Allergy to Cannabis and Related Essential Oils7
Atopic Dermatitis is a Risk Factor for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis7
Formaldehyde Release From Predispersed Tattoo Inks: Analysis Using the Chromotropic Acid Method7
Efficacy of Dupilumab in Children 6 Months to 11 Years Old With Atopic Dermatitis: A Retrospective Real-World Study in China6
Bilateral Association Between Atopic Dermatitis® and Alopecia Areata: A Systematic Review and Meta-Analysis6
Usefulness of Patch Testing With Patient's Own Products in the Diagnosis of Allergic Contact Dermatitis6
Patch Testing in Drug Eruptions: Practical Aspects and Literature Review of Eruptions and Culprit Drugs6
YouTube as a Source of Information on Contact Dermatitis6
Dupilumab-Induced Palmoplantar Psoriasis: Is It True Psoriasis?6
Dupilumab for Atopic Dermatitis—From Clinical Trials to Molecular and Cellular Mechanisms6
Update on Contact Sensitization in the Older Adult Population6
Methylchloroisothiazolinone and/or Methylisothiazolinone Contact Allergies in Thailand6
Long-Term Narrowband UV-B Efficacy in Moderate to Severe Atopic Dermatitis6
Analysis of Hexavalent Chromium in Cement Samples From Countries Within and Outside the EU: A Study From the International Contact Dermatitis Research Group6
Readability, Quality, and Timeliness of Online Health Resources for Atopic Dermatitis6
Exploring the Relationship Between Dermatology Life Quality Index, Eczema Area and Severity Index, and Sleep Numerical Rating Scale and Pruritus Numerical Rating Scale in Patients with Atopic Dermatit6
Anti-inflammatory Effect of Cannabidiol and Palmitoylethanolamide Containing Topical Formulation on Skin in a 12-O-Tetradecanoylphorbol-13-Acetate–Induced Dermatitis Model in Mice6
Trends in Patch Testing With the Mayo Clinic Standard Series, 2017–20215
High Levels of Psychological Distress, Sleep Disturbance, and Alcohol Use Disorder in Adults With Atopic Dermatitis5
Transitioning From Immunosuppressants to Dupilumab in Pediatric Atopic Dermatitis5
Systemic Treatment of Cutaneous Adverse Events After Immune Checkpoint Inhibitor Therapy: A Review5
Real-World Clinical Experience of Dupilumab in the Treatment of Chronic Palmo-Plantar Eczema in Patients with Moderate-Severe Atopic Dermatitis: 52-Week Follow-Up5
Friction-Induced Skin Disorders—A Review5
Lanolin Allergic Reactions: North American Contact Dermatitis Group Experience, 2001 to 20185
Allergic Contact Dermatitis Associated With Religious Practices: Review of the Literature5
Formaldehyde in Electronic Cigarette Liquid (Aerosolized Liquid)5
Contact Dermatitis From Gum Mastic (Pistacia lentiscus) and Gum Storax (Liquidambar styraciflua) in Mastisol-Allergic Patients5
Neonatal Bacillus Calmette-Guérin Vaccination to Prevent Early-Life Eczema: A Systematic Review and Meta-analysis5
Isothiazolinones Common in Children's Toy Slime5
Longitudinal Course of Sleep Disturbance and Relationship With Itch in Adult Atopic Dermatitis in Clinical Practice5
Wearable Woes: Allergens in Diabetic Devices5
Burden of Disease and Unmet Needs in Atopic Dermatitis: Results From a Patient Survey5
Results of Switching From Tofacitinib to Upadacitinib in Patients With Atopic Dermatitis: A Retrospective Medical Record Review5
Patch Testing to Carvone: North American Contact Dermatitis Group Experience, 2009 to 20185
Concurrent Atopic Dermatitis and Psoriasis Successfully Treated With Brodalumab5
Meeting the Needs of Patients With Atopic Dermatitis: A Multidisciplinary Approach5
Self-Reported Hand Eczema: Assessment of Prevalence and Risk Factors in Health Care Versus Non–Health Care Workers During the COVID-19 Pandemic5
Patch Testing in Patients With Severe Atopic Dermatitis Treated With Dupilumab: A Multicentric Approach in Spain5
Hand Dermatitis in the Time of COVID-19: A Review of Occupational Irritant Contact Dermatitis4
Patterns of Allergic Contact Dermatitis in African Americans in a Major Metropolitan Area Over a 10-Year Period4
Contact Allergens in Prescription Topical Ophthalmic Medications4
COVID-19 Outcomes in Pediatric Patients With Atopic Dermatitis: A Multicenter Analysis4
Development of an Eczema Area and Severity Index Atlas for Diverse Skin Types4
Contact Allergy Cross-reactions and Thresholds: A Review4
Occupational Contact Dermatitis Caused by Artichokes4
Work-Related and Personal Predictors of Hand Eczema in Physicians and Dentists: Results From a Field Study4
American Contact Dermatitis Society Position Statement: Dermatitis and Skin of Color4
Consort Allergic Contact Dermatitis: A Systematic Review4
Allergic Contact Dermatitis in the Older Adults: A Comparative Cross-Sectional Study4
Janus Kinase Inhibition in the Treatment of Prurigo Nodularis4
Pediatric Contact Dermatitis: A 10-Year Multicenter Retrospective Study4
Reliability and Longitudinal Course of Itch/Scratch Severity in Adults With Atopic Dermatitis4
Treatment of Checkpoint Inhibitor–Induced Vitiligo in a Patient With Metastatic Renal Cell Cancer4
Allergic Contact Dermatitis and Patch Testing in Skin of Color Patients4
Patch Test Reactions Associated With Topical Medications: A Retrospective Analysis of the North American Contact Dermatitis Group Data (2001–2018)4
Impact of Extracorporeal Photopheresis on Blood Parameters of Atopic Dermatitis Patients4
Prevalence, Predictors, and Longitudinal Course of Sexual Dysfunction in Adults With Atopic Dermatitis4
Lanolin4
Atopic Dermatitis as a Risk Factor for Herpes Zoster Infection Independent of Treatment: A Nationwide Population-Based Cohort Study4
Which Clinical Measurement Tools for Atopic Dermatitis Severity Make the Most Sense in Clinical Practice?4
Topical Crisaborole in the Treatment of Atopic Hand Dermatitis: A Retrospective Chart Review4
Discordance Between Diagnosis Tools for Assessing Eczema in Infants: A Challenge for Intervention Trials4
The Burden of Coronavirus Disease 2019 and Its Complications in Patients With Atopic Dermatitis—A Nested Case-Control Study4
A Survey of Skin Reactions Associated With Acrylic Nail Cosmetics, With a Focus on Home Kits: Is There a Need for Regulation?4
Patch Test Results to European Baseline Series in Turkey: A Prospective and Multicenter Study4
A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis4
Patients' and Caregivers' Preferences for Mental Health Care and Support in Atopic Dermatitis4
Sulfites: Allergen of the Year 20243
An Approach to Hypereosinophilic Syndrome Presenting With Cutaneous Features3
Patch Testing With Cobalt in Adults: A North American Contact Dermatitis Group Experience, 2001–20183
Objective Sleep in Atopic Dermatitis: A Meta-Analysis3
A Retrospective Review of Late Delayed Positive Patch Testing Greater Than Day 8 at Mayo Clinic From 2001 to 20203
Long-Term North American Trend in Patch Test Reactions: A 32-Year Statistical Overview (1984–2016)3
Dupilumab-Induced Extrafacial Paradoxical Persistent Erythema in an Atopic Dermatitis Patient3
Trends in Patch Testing in the Medicare Part B Fee-for-Service Population3
Men's Facial Moisturizers in the Metrosexual Era3
First Short-Term Effectiveness and Security Data of Tralokinumab in Severe Atopic Dermatitis® in Real Clinical Practice3
The 2-Methoxymethyl Modification of p-Phenylenediamine Reduces the Sensitization Risk for Hairdressers to Hair Dyes—An Occupational Hand Exposure–Based Risk Assessment3
Atopic Dermatitis Is Associated With Lower Patient Satisfaction in US Adults3
Atopic Dermatitis and Difficult-to-Treat Areas: A Case Series of Four Patients With Dupilumab-Resistant Primary Atopic Blepharitis and Successfully Treated With Upadacitinib3
Assessment and Monitoring Challenges Among Patients With Moderate-to-Severe Atopic Dermatitis Across Fitzpatrick Skin Types: A Photographic Review and Case Series3
Atopic Dermatitis Biomarkers and the Movement Toward Personalized Treatment3
Allergic Sensitization to Nickel and Implanted Metal Devices: A Perspective3
Patch Testing With Benzophenone-3 and -4: The North American Contact Dermatitis Group Experience, 2013–20203
Methyldibromoglutaronitrile: Increased Incidence, but Lacks Clinical Relevance3
Cross-Reactivity Between Propylene Glycol and Butylene Glycol3
Cutaneous Comorbidities Associated With Atopic Dermatitis in Israel: A Retrospective Real-World Data Analysis3
A Case of Pigmented Contact Dermatitis Caused by Ethylhexylglycerin3
Patient and Caregiver Perspectives on the Relationship Between Atopic Dermatitis Symptoms and Mental Health3
The Frequency and Utility of Drug Cessation Trials in Older Adults With Chronic Eczematous Dermatitis of Unknown Etiology: A Retrospective Cohort Study3
Multiyear Group and Medical Center Patch Test Frequency Data: Confounding Variables3
Efficacy and Safety of Tralokinumab in Real Life: Possible Predictive Rapid Response Factors3
Contact Allergy to Two Aluminum Salts in Consecutively Patch-Tested Dermatitis Patients3
Incidence of Bacterial and Nonbacterial Conjunctivitis in Patients With Atopic Dermatitis Treated With Dupilumab: A US Multidatabase Cohort Study3
Patch Testing to Paraphenylenediamine: The North American Contact Dermatitis Group Experience (1994–2018)3
Assessment and Management of Sleep Disturbances in Atopic Dermatitis: A Review3
The Prevalence of Type IV Hypersensitivity in Patients With Lichen Planopilaris and Frontal Fibrosing Alopecia3
Too Much of a Good Thing? Allergic Contact Dermatitis to Pimecrolimus3
Trichoscopy Features of Allergic Contact Dermatitis of the Scalp: A Prospective Case Series3
Low Prevalence of Fragrance Contact Allergy Among Turkish Population: A 24-Year, Cross-Sectional, Tertiary Single-Center, Retrospective Study3
Prevalence of Contact Allergy to Nickel: A Retrospective Chart Review3
Rate of Patch Testing Induced Anaphylaxis3
Validity of the Skindex Mini in Patients With Atopic Dermatitis3
Formaldehyde Release From Eyelash Glues: Analysis Using the Chromotropic Acid Method3
Allergic Contact Dermatitis to the Ethylenediamine Component of Aminophylline in a Neck Cream3
Effectiveness of a Skin Care Program With a Cream Containing Ceramide C and a Personalized Training for Secondary Prevention of Hand Contact Dermatitis3
Demonstration of Convolutional Neural Networks to Determine Patch Test Reactivity3
Association of Childhood Atopic Dermatitis With a Higher Risk of Health Care Utilization and Drug Use for Asthma: A Nationwide Cohort Study3
Successful Treatment of Atopic Hand and Foot Eczema With Oral Janus Kinase 1 Inhibition3
Childhood Atopic Dermatitis Is Not Associated With Maternal Alcohol Use During Pregnancy or Adolescent Alcohol Use3
Patch Testing of Mercaptobenzothiazole and Mercapto Mix: The North American Contact Dermatitis Group Experience, 1994–20163
Dupilumab for Atopic Dermatitis—From Clinical Trials to Molecular and Cellular Mechanisms3
Remission of Severe Eyelid Dermatitis With a Topical Janus Kinase Inhibitor3
Friction-Aggravated Skin Disorders—A Review of Mechanism and Related Diseases3
Analysis of Contact Allergens in Polyvinyl Chloride Examination Gloves in the United States3
Association of Adult Atopic Dermatitis Severity With Decreased Physical Activity: A Cross-sectional Study3
Patch Testing to Methyldibromoglutaronitrile/Phenoxyethanol: North American Contact Dermatitis Group Experience, 1994–20183
Risk Factors of Onset Time and Persistence of Atopic Dermatitis in Children Under Age 5 Years: A Cross-Sectional Study3
0.064741134643555